Correlation Between ATT and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATT and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Unicycive Therapeutics, you can compare the effects of market volatilities on ATT and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Unicycive Therapeutics.
Diversification Opportunities for ATT and Unicycive Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ATT and Unicycive is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of ATT i.e., ATT and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between ATT and Unicycive Therapeutics
Taking into account the 90-day investment horizon ATT Inc is expected to generate 0.19 times more return on investment than Unicycive Therapeutics. However, ATT Inc is 5.25 times less risky than Unicycive Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 1,580 in ATT Inc on September 24, 2024 and sell it today you would earn a total of 695.00 from holding ATT Inc or generate 43.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
ATT Inc vs. Unicycive Therapeutics
Performance |
Timeline |
ATT Inc |
Unicycive Therapeutics |
ATT and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ATT and Unicycive Therapeutics
The main advantage of trading using opposite ATT and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.ATT vs. Grab Holdings | ATT vs. Cadence Design Systems | ATT vs. Aquagold International | ATT vs. Morningstar Unconstrained Allocation |
Unicycive Therapeutics vs. Fate Therapeutics | Unicycive Therapeutics vs. Sana Biotechnology | Unicycive Therapeutics vs. Caribou Biosciences | Unicycive Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |